| Antigen | 13-aa peptide from human Nogo-A (1); Designation (#NOGOA12-P, control/blocking peptide) conjugated to KLH; epitope location ~ between the putative 2nd-3rd transmembrane domain |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | The human NogoA12-P peptide sequence is conserved in all 3 isoforms (human Nogo A-C). It is 92% identical in mouse, rat Nogo or rat foocen-m1/2 protein and 100% in monkey Nogo-A. NogoA12-P is within the 25-aa region identified for the inhibition of neurite outgrowth (1). Antibody crossreactivity of NogoA12 in various species is not established |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |